🇺🇸 FDA
Patent

US 7323171

Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 7323171 (Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
68
CPC classes
A61K, A61K2039/505, A61K38/00